Dow Jones

38 686,32

1,51%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Thimble Point Acquisition Corporation (THMA)
Thimble Point Acquisition Corporation (THMA) Actualités

THMA

Thimble Point Acquisition (THMA)

Thimble Point Acquisition Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:THMA

1 2 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
02/05/2023	19h37	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:THMA	Thimble Point Acquisition Corporation
12/04/2023	22h34	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:THMA	Thimble Point Acquisition Corporation
10/04/2023	22h37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:THMA	Thimble Point Acquisition Corporation
31/03/2023	22h04	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:THMA	Thimble Point Acquisition Corporation
09/02/2023	22h43	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:THMA	Thimble Point Acquisition Corporation
24/01/2023	22h08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:THMA	Thimble Point Acquisition Corporation
10/01/2023	22h21	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:THMA	Thimble Point Acquisition Corporation
04/01/2023	22h21	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:THMA	Thimble Point Acquisition Corporation
04/01/2023	12h03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:THMA	Thimble Point Acquisition Corporation
03/01/2023	13h38	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:THMA	Thimble Point Acquisition Corporation
14/11/2022	23h53	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:THMA	Thimble Point Acquisition Corporation
16/06/2022	22h11	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:THMA	Thimble Point Acquisition Corporation
02/05/2022	22h06	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:THMA	Thimble Point Acquisition Corporation
02/05/2022	22h06	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:THMA	Thimble Point Acquisition Corporation
29/03/2022	12h07	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:THMA	Thimble Point Acquisition Corporation
14/02/2022	12h35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:THMA	Thimble Point Acquisition Corporation
23/12/2021	22h41	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:THMA	Thimble Point Acquisition Corporation
13/12/2021	22h31	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:THMA	Thimble Point Acquisition Corporation
13/12/2021	22h17	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:THMA	Thimble Point Acquisition Corporation
03/12/2021	22h12	Business Wire	Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics Company	NASDAQ:THMA	Thimble Point Acquisition Corporation
30/11/2021	23h05	Edgar (US Regulatory)	Sec Staff Action/letter (sec Staff)	NASDAQ:THMA	Thimble Point Acquisition Corporation
23/11/2021	14h00	Business Wire	Pear Therapeutics to Participate in Evercore ISI Fourth Annual HealthCONx Conference	NASDAQ:THMA	Thimble Point Acquisition Corporation
22/11/2021	22h52	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:THMA	Thimble Point Acquisition Corporation
22/11/2021	14h00	Business Wire	Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder	NASDAQ:THMA	Thimble Point Acquisition Corporation
15/11/2021	14h02	Business Wire	Pear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue Guidance	NASDAQ:THMA	Thimble Point Acquisition Corporation
15/11/2021	14h00	Business Wire	Thimble Point and Pear Therapeutics Announce Additional $50 Million in Committed Capital to Fund Business Plan	NASDAQ:THMA	Thimble Point Acquisition Corporation
09/11/2021	14h00	Business Wire	Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product List	NASDAQ:THMA	Thimble Point Acquisition Corporation
08/11/2021	22h05	Business Wire	Pear Therapeutics to Participate in the BTIG Digital Health Forum	NASDAQ:THMA	Thimble Point Acquisition Corporation
25/10/2021	15h21	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:THMA	Thimble Point Acquisition Corporation
09/09/2021	14h35	Business Wire	Pear and Thimble Point Announce Nominees to Board of Directors	NASDAQ:THMA	Thimble Point Acquisition Corporation